Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis
- PMID: 17223544
- DOI: 10.1016/j.ejca.2006.11.010
Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis
Abstract
Obesity is a risk factor for several hormone-related cancers but evidence for an effect on risk of epithelial ovarian cancer remains inconclusive. Many studies evaluating this association have had insufficient statistical power to detect modest effects, particularly for histological subtypes of ovarian cancer. We have therefore assembled the published evidence on obesity and ovarian cancer in a systematic literature review and meta-analysis. We identified eligible studies using Medline and manual review of retrieved references, and included all population-based studies that assessed the association between overweight, body mass index (BMI25-29.9) and obesity (BMI30) and histologically confirmed ovarian cancer. Meta-analysis was restricted to those studies that expressed effect as an odds ratio (OR), risk ratio, or standardised incidence ratio and 95% confidence interval (CI). We identified 28 eligible studies, of which 16 on adult obesity and 9 on obesity in early adulthood were suitable for meta-analysis. Overall, 24 of 28 studies reported a positive association between obesity and ovarian cancer, and in 10 this reached statistical significance. The pooled effect estimate for adult obesity was 1.3 (95%CI1.1-1.5) with a smaller increased risk for overweight (OR1.2;95%CI1.0-1.3). The pooled OR was stronger among case-control studies (OR=1.5) than cohort studies (OR=1.1). Overweight/obesity in early adulthood was also associated with an increased risk of ovarian cancer. There was no evidence that the association varied for the different histological subtypes of ovarian cancer. Ovarian cancer should be added to the list of cancers likely to be related to obesity.
Similar articles
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2. Cochrane Database Syst Rev. 2018. PMID: 30039871 Free PMC article.
-
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3. Cochrane Database Syst Rev. 2022. PMID: 35866378 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
Cited by
-
Influence of interdisciplinary frailty screening on perioperative complication rates in elderly ovarian cancer patients: results of a retrospective observational study.Arch Gynecol Obstet. 2023 Jun;307(6):1929-1940. doi: 10.1007/s00404-022-06850-4. Epub 2022 Nov 24. Arch Gynecol Obstet. 2023. PMID: 36434440 Free PMC article.
-
Racial differences in the association of body mass index and ovarian cancer risk in the OCWAA Consortium.Br J Cancer. 2022 Nov;127(11):1983-1990. doi: 10.1038/s41416-022-01981-6. Epub 2022 Sep 22. Br J Cancer. 2022. PMID: 36138071 Free PMC article.
-
Risk Factors for Ovarian Cancer: An Umbrella Review of the Literature.Cancers (Basel). 2022 May 30;14(11):2708. doi: 10.3390/cancers14112708. Cancers (Basel). 2022. PMID: 35681688 Free PMC article. Review.
-
Inflammation and tumor progression: signaling pathways and targeted intervention.Signal Transduct Target Ther. 2021 Jul 12;6(1):263. doi: 10.1038/s41392-021-00658-5. Signal Transduct Target Ther. 2021. PMID: 34248142 Free PMC article.
-
Health inequality and improvement gap in the prevalence of gynecological cancers among perimenopausal women globally, 1990-2019.BMC Public Health. 2025 Feb 12;25(1):590. doi: 10.1186/s12889-025-21807-3. BMC Public Health. 2025. PMID: 39939993 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical